Genetic Technologies (GENE) Surges on University of Melbourne Development Agreement

November 29, 2016 9:42 AM EST
Get Alerts GENE Hot Sheet
Trade GENE Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with's Ratings Insider Elite. Get your Free Trial here.

Genetic Technologies (NASDAQ: GENE) is surging 70% off the open after the company announced the signing of an exclusive worldwide license agreement with The University of Melbourne for the development and commercialisation of a novel colorectal cancer (CRC) risk assessment test.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Momentum Movers, Trader Talk

Add Your Comment